Dr. Andrew Campbell

Andrew Campbell, PhDAndrew Campbell, PhD, HCLD (ABB)
Associate Director, Clinical Genomics Development

100 North Academy Avenue
Danville, PA 17822
1 800 695 6491

Dr. Campbell is an associate of Geisinger Medical Laboratories at Danville, Pennsylvania, where he serves as the Associate Director of Clinical Genomics Development


Dr. Campbell received his PhD in Pathology from and completed a postdoctoral fellowship in Biomedical Genetics and Environmental Medicine at the University of Rochester, New York.

Board Certifications

Dr. Campbell is board certified by the American Board of Bioanalysis as a high-complexity clinical laboratory direcator in the discipline of molecular diagnostics.

Professional Affiliations:

Association for Molecular Pathology

Research Interests:

Molecular biology and genetics, oncology, immunology, neurobiology. Dr. Campbell specializes in DNA sequencing and analysis.

Recent Academic Activity

Publications in Peer-Reviewed Journals:

Ding Y, Campbell A, Zhang X, Fu K, Yuan J. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Pathology. 2020;2S0031-3025(20):30890-4.

Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P. Biclonal presentation of lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. Pathology. 2019;51(3):340-343.

Campbell A, Hogestyn JM, Folts CJ, Lopez B, Proschel C, Mock D, Mayer-Proschel M. Expression of the Human Herpesvirus 6A Latency-Associated Transcript U94A Disrupts Human Oligodendrocyte Progenitor Migration. Sci Rep. 2017;7(1):3978.

Abstracts, Posters, and Other Presentations:

Katerji H, Katerji R, Campbell A, Rothberg P, Ding Y. Clinical Utilization of Next Generation Sequencing based Clonality Assays for Immunoglobulin Heavy Chain in Evaluating Suspected B-cell Proliferation.. Abstract. ASCP 2019 Annual Meeting, Phoenix, Arizona, September 11-13, 2019.

Campbell A, Crowe W, Spence J, Spence J, Rothberg P, Ding Y. Identification of FLT3 ITD using Next-Generation Sequencing (NGS): A single institution’s experience. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Campbell A, Crowe W, Rothberg P, Ding Y.. Clinical Evaluation of the Archer VariantPlex Myeloid Panel for Mutation Profiling in Myeloid Neoplasms. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Reyes-Barron C, Buscaglia B, Campbell A, Hicks D, Ding Y. Next Generation Sequencing for Quantitative Measurement of Human Epidermal Growth Factor Receptor-2 (HER2) Amplification: a Comparative Study. Poster. Association for Molecular Pathology (AMP) 2018, San Antonio, Texas, November 1-3, 2018.

Reyes-Barron C, Campbell A, Rothberg P, Burack R, Ding Y. Next Generation Sequencing-Assays Detect B-Lymphocyte Clonality in Formalin-Fixed Paraffin Embedded Specimens of Classical Hodgkin Lymphoma without Microdissection. Poster Presentation. USCAP 107th Annual Meeting, Vancouver, British Columbia, March 17-23, 2018.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2023 Geisinger Health System.   All rights reserved.